IP Verse

Compositions Comprising Bacterial Strains - EP3209381

The patent EP3209381 was granted to CJ Bioscience on Nov 14, 2018. The application was originally filed on Nov 23, 2016 under application number EP16804857A. The patent is currently recorded with a legal status of "Revoked".

EP3209381

CJ BIOSCIENCE
Application Number
EP16804857A
Filing Date
Nov 23, 2016
Status
Revoked
Dec 1, 2023
Grant Date
Nov 14, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BRADYAug 14, 2019ABEL & IMRAY -
HOFFMANN EITLEAug 14, 2019HOFFMANN EITLE -

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2014121304
INTERNATIONAL-SEARCH-REPORTWO2015095241
INTERNATIONAL-SEARCH-REPORTWO2015156419
OPPOSITIONUS2014341921
OPPOSITIONWO0207741
OPPOSITIONWO2013080561
OPPOSITIONWO2014121304
OPPOSITIONWO2014145970
OPPOSITIONWO2015006355
OPPOSITIONWO2015095241
OPPOSITIONWO2015156419
OPPOSITIONWO2016086205
OPPOSITIONWO2016209806

Non-Patent Literature (NPL) Citations (37) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Alignment of Opposed Patent SEQ ID NO :1 (16S rRNA sequence of prior art E. ramosum strain DSM 1402) vs. SEQ ID NO :3 (''MRX027-
OPPOSITION- ATARASHI et al., Nature, (20130000), vol. 500, no. 7461, pages 232 - 236-
OPPOSITION- DRANCOURT et al., "16S Ribosomal DNA Sequence Analysis of a Large Collection of Environmental and Clinical Unidentifiable Bacterial Isolates", J Clin Microbiol, (20000000), vol. 38, no. 19, pages 3623 - 3630, XP002247318-
OPPOSITION- "Erysipelatoclostridium ramosum strain JCM 1298 16S ribosomal RNA, partial sequence", nucleotide, (201903121), Database accession no. 113243.1, XP055635025-
OPPOSITION- "Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease", Inflamm Bowel Dis., (20150000), vol. 21, no. 3, pages 556 - 63-
OPPOSITION- GÁLVEZ, "Role of Th17 Cells in the Pathogenesis of Human IBD", Inflammation, vol. 2014, (20140000), URL: http://dx.doi.org/10.1155/2014/928461-
OPPOSITION- GONG et al., "T he Th17/Treg Immune Imbalance in Ulcerative Colitis Disease in a Chinese Han Population", Mediators Inflamm., vol. 2016, (20160000), URL: http://dx.doi.org/10.1155/2016/7089137-
OPPOSITION- LEBER et al., "Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection", PloS ONE 10(7, (20150000), page e0134849-
OPPOSITION- NCBI, Database accession no. NCBI:txid1547-
OPPOSITION- SEFIK et al., "Individual Microbes Shape Various Parts of the Immune System", Graduate School of Arts & Sciences, (20150000), XP055633948-
OPPOSITION- YUTIN et al., "A genomic update on clostridial phylogeny : Gram- negative spore formers and other misplaced clostridia", Environmental Microbiology, (20130000), vol. 15, no. 10, pages 2631 - 2341-
OPPOSITION- YOUNGSTER et al., "Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection", JAMA, (20140000), vol. 312, no. 17, doi:10.1001/jama.2014.13875, pages 1772 - 8, XP009189475
OPPOSITION- BAKKEN, "Fecal bacteriotherapy for recurrent Clostridium difficile infection", Anaerobe, (20090000), vol. 15, doi:10.1016/j.anaerobe.2009.09.007, pages 285 - 289, XP002754036
OPPOSITION- BELKAID et al., "Role of the Microbiota in Immunity and Inflammation", Cell, (20140000), vol. 157, no. 1, doi:10.1016/j.cell.2014.03.011, pages 121 - 141, XP028601900
OPPOSITION- GARIDOU et al., "The Gut microbiota Regulates Intestinal CD 4 T cells Expressing RORyt and Controls Metabolic Disease", Cell Metabolism, (20150000), vol. 22, pages 100 - 112, XP055633958
OPPOSITION- TVEDE et al., "Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000- 2012", Clin Microbiol Infect, (20140000), vol. 21, doi:10.1016/j.cmi.2014.07.003, pages 48 - 53, XP002754247
OPPOSITION- TVEDE et al., "Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012", Clin Microbiol Infect., (20141012), vol. 21, no. 1, doi:10.1016/j.cmi.2014.07.003, pages 48 - 53, XP002754247
OPPOSITION- TACKE et al., "First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe", Clin Microbiol Infect, (20150708), vol. 21, no. 11, pages e82 - 4, XP055635040
OPPOSITION- FAROOQ et al., "Pseudomembranous Colitis", HHS Public Access, (20150000), vol. 61, no. 5, doi:10.1016/j.disamonth.2015.01.006, pages 181 - 206, XP009193313
OPPOSITION- TVEDE et al., "Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients", Lancet, (19890000), vol. 1, no. 8648, doi:10.1016/S0140-6736(89)92749-9, pages 1156 - 60, XP000985182
OPPOSITION- TVEDE et al., "Bacteriotherapy For Chronic Relapsing Clostridium Difficile Diarrhoea In Six Patients", The Lancet, (19890000), vol. 1, no. 8648, doi:10.1016/S0140-6736(89)92749-9, pages 1156 - 60, XP000985182
OPPOSITION- RUPNIK et al., "Clostridium difficile infection: new developments in epidemiology and pathogenesis", Nature Reviews Microbiology, (20090000), vol. 7, no. 7, doi:10.1038/nrmicro2164, pages 526 - 36, XP009169073
OPPOSITION- PETROF et al., "From Stool Transplants to Next-generation Microbiota Therapeutics", Gastroenterology, (20140000), vol. 146, no. 6, pages 1573 - 1582, XP055633950
OPPOSITION- PETROF et al., "From Stool Transplants to Next-Generation Microbiota Therapeutics", Gastroenterology, (20140000), vol. 146, pages 1573 - 1582, XP055633950
OPPOSITION- MOAYYEDI et al., "Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial", Gastroenterology, (20150407), vol. 149, no. 1, pages 102 - 109, XP055631556
OPPOSITION- MOHANDAS et al., "Clostridium ramosum Bacteremia and Osteomyelitis in a Patient with Infected Pressure Sores", Infectious Disease in Clinical Practice, (20010000), vol. 10, no. 2, pages 123 - 124, XP055635039
OPPOSITION- DAHYA et al., "Clostridium ramosum Osteomyelitis in an Immunocompetent Patient After Traumatic Injury", Infectious Diseases in Clinical Practice, (20150000), vol. 23, doi:10.1097/IPC.0000000000000209, pages 102 - 104, XP009193312
OPPOSITION- SOLOMON et al., "Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses", Journal of Medical Microbiology, (20130000), vol. 62, doi:10.1099/jmm.0.058479-0, pages 1453 - 1460, XP055485470
OPPOSITION- BAGGE et al., "Diversity of spore-forming bacteria in cattle manure, slaughterhouse waste and samples from biogas plants", Journal of Applied Microbiology, (20100000), vol. 109, doi:10.1111/j.1365-2672.2010.04790.x, pages 1549 - 1565, XP009193328
OPPOSITION- SMITH et al., "The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis", Science, (20130000), vol. 341, no. 6145, doi:10.1126/science.1241165, pages 569 - 573, XP055247108
OPPOSITION- SEFIK et al., "Individual intestinal symbionts induce a distinct population of RORy+ regulatory T cells", Science, (20150000), vol. 349, no. 6251, doi:10.1126/science.aaa9420, pages 993 - 997, XP055341529
OPPOSITION- JUSTESEN et al., "16S rRNA Gene Sequencing in Routine Identification of Anaerobic Bacteria Isolated from Blood Cultures", J Clin Microbiol, (20100000), vol. 48, no. 3, doi:10.1128/JCM.02075-09, pages 946 - 948, XP055550387
OPPOSITION- SHEN, "Clostridium difficile Toxins: Mediators of Inflammation", J Innate Immun., (20120000), vol. 4, no. 2, pages 149 - 158, XP055635031
OPPOSITION- CHU et al., "Assessment and In Vivo Scoring of Murine Experimental Autoimmune Uveoretinitis Using Optical Coherence Tomography", PLOS, (20130000), vol. 8, no. 5, page e63002, XP055633952
OPPOSITION- RAO et al., "The Systemic Inflammatory Response to Clostridium difficile Infection", PLoS One, (20140000), vol. 9, no. 3, page e92578, XP055635033
OPPOSITION- LLOSA et al., "Interleukin-17 and type 17 helper T cells in cancer management and research", Immunotargets Ther., (20140000), vol. 3, doi:10.2147/ITT.S56529, pages 39 - 54, XP055550455
OPPOSITION- NARUSHIMA et al., "Characterisation of the 17 strains of regulatory T cell -inducing human-derived Clostridia", Gut Microbes, (20140000), vol. 5, no. 3, pages 333 - 339, XP055178318

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents